Loading...

We've got a brand new version of Simply Wall St! Try it out

Cyanotech

Nasdaq:CYAN
Snowflake Description

Imperfect balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CYAN
Nasdaq
$15M
Market Cap
  1. Home
  2. US
  3. Household
Company description

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The last earnings update was 91 days ago. More info.


Add to Portfolio Compare Print
CYAN Share Price and Events
7 Day Returns
1.4%
NasdaqCM:CYAN
2.2%
US Personal Products
0.3%
US Market
1 Year Returns
-29.2%
NasdaqCM:CYAN
20.5%
US Personal Products
12.5%
US Market
CYAN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Cyanotech (CYAN) 1.4% 6.7% -1.3% -29.2% -36.1% -67.8%
US Personal Products 2.2% -1.1% 5.5% 20.5% 54.3% 59.2%
US Market 0.3% 4.1% 5.6% 12.5% 39.4% 44.7%
1 Year Return vs Industry and Market
  • CYAN underperformed the Personal Products industry which returned 20.5% over the past year.
  • CYAN underperformed the Market in United States of America which returned 12.5% over the past year.
Price Volatility
CYAN
Industry
5yr Volatility vs Market

CYAN Value

 Is Cyanotech undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Cyanotech. This is due to cash flow or dividend data being unavailable. The share price is $2.526.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Cyanotech's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Cyanotech's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:CYAN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-0.42
NasdaqCM:CYAN Share Price ** NasdaqCM (2019-11-12) in USD $2.53
United States of America Personal Products Industry PE Ratio Median Figure of 21 Publicly-Listed Personal Products Companies 17.08x
United States of America Market PE Ratio Median Figure of 2,922 Publicly-Listed Companies 18.25x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Cyanotech.

NasdaqCM:CYAN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:CYAN Share Price ÷ EPS (both in USD)

= 2.53 ÷ -0.42

-6.02x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cyanotech is loss making, we can't compare its value to the US Personal Products industry average.
  • Cyanotech is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Cyanotech's expected growth come at a high price?
Raw Data
NasdaqCM:CYAN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -6.02x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Personal Products Industry PEG Ratio Median Figure of 6 Publicly-Listed Personal Products Companies 2.56x
United States of America Market PEG Ratio Median Figure of 2,023 Publicly-Listed Companies 1.46x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Cyanotech, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Cyanotech's assets?
Raw Data
NasdaqCM:CYAN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $2.56
NasdaqCM:CYAN Share Price * NasdaqCM (2019-11-12) in USD $2.53
United States of America Personal Products Industry PB Ratio Median Figure of 43 Publicly-Listed Personal Products Companies 2.65x
United States of America Market PB Ratio Median Figure of 5,066 Publicly-Listed Companies 1.74x
NasdaqCM:CYAN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:CYAN Share Price ÷ Book Value per Share (both in USD)

= 2.53 ÷ 2.56

0.98x

* Primary Listing of Cyanotech.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cyanotech is good value based on assets compared to the US Personal Products industry average.
X
Value checks
We assess Cyanotech's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Cyanotech has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

CYAN Future Performance

 How is Cyanotech expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cyanotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
17.7%
Expected Personal Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Cyanotech expected to grow at an attractive rate?
  • Unable to compare Cyanotech's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Cyanotech's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Cyanotech's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:CYAN Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 17.7%
United States of America Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 6.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.2%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:CYAN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:CYAN Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 31 -1 -2
2019-03-31 30 -1 -4
2018-12-31 32 0 -3
2018-09-30 31 -1 -2
2018-06-30 32 0 -1
2018-03-31 34 1 1
2017-12-31 33 2 2
2017-09-30 32 2 0
2017-06-30 34 1 0
2017-03-31 32 1 -1
2016-12-31 33 1 -5
2016-09-30 33 2 -5

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Cyanotech is high growth as no earnings estimate data is available.
  • Unable to determine if Cyanotech is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:CYAN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Cyanotech Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CYAN Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -0.42
2019-03-31 -0.62
2018-12-31 -0.55
2018-09-30 -0.41
2018-06-30 -0.13
2018-03-31 0.18
2017-12-31 0.32
2017-09-30 0.06
2017-06-30 0.00
2017-03-31 -0.21
2016-12-31 -0.89
2016-09-30 -0.87

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Cyanotech will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of CYAN’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Cyanotech's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Household companies here
  3. Cyanotech's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Cyanotech's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Cyanotech has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

CYAN Past Performance

  How has Cyanotech performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Cyanotech's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Cyanotech does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Cyanotech's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Cyanotech's 1-year growth to the US Personal Products industry average as it is not currently profitable.
Earnings and Revenue History
Cyanotech's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Cyanotech Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CYAN Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 31.13 -2.45 12.68 0.90
2019-03-31 30.20 -3.60 12.54 0.92
2018-12-31 32.24 -3.18 11.99 0.77
2018-09-30 31.35 -2.36 11.57 0.69
2018-06-30 32.45 -0.75 11.35 0.63
2018-03-31 34.12 1.03 11.39 0.56
2017-12-31 33.27 1.81 11.36 0.57
2017-09-30 31.72 0.35 11.26 0.57
2017-06-30 33.53 -0.02 11.89 0.57
2017-03-31 32.04 -1.22 12.31 0.59
2016-12-31 32.99 -5.00 12.49 0.62
2016-09-30 32.91 -4.90 12.23 0.61
2016-06-30 31.57 -4.98 11.84 0.62
2016-03-31 31.84 -4.40 12.02 0.63
2015-12-31 32.19 -0.51 11.29 0.62
2015-09-30 34.35 0.20 11.96 0.64
2015-06-30 33.78 0.25 12.49 0.58
2015-03-31 33.81 -0.02 13.63 0.52
2014-12-31 31.79 -0.45 14.10 0.45
2014-09-30 29.54 -0.87 13.50 0.40
2014-06-30 28.89 -0.83 12.31 0.47
2014-03-31 28.18 -0.42 10.88 0.47
2013-12-31 28.54 2.81 9.72 0.47
2013-09-30 28.35 3.38 9.20 0.41
2013-06-30 27.98 3.75 8.93 0.32
2013-03-31 27.46 4.16 8.36 0.26
2012-12-31 26.67 2.74 8.00 0.27

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Cyanotech has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Cyanotech has efficiently used its assets last year compared to the US Personal Products industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Cyanotech improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Cyanotech's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Cyanotech has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

CYAN Health

 How is Cyanotech's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Cyanotech's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Cyanotech is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Cyanotech's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Cyanotech's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Cyanotech Company Filings, last reported 4 months ago.

NasdaqCM:CYAN Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 15.10 9.28 1.06
2019-03-31 14.91 8.12 0.84
2018-12-31 16.25 8.07 1.57
2018-09-30 15.93 7.90 0.66
2018-06-30 16.85 7.55 0.94
2018-03-31 18.11 6.95 1.33
2017-12-31 19.09 7.10 1.76
2017-09-30 17.93 7.09 2.10
2017-06-30 17.14 7.23 1.30
2017-03-31 16.61 7.25 1.41
2016-12-31 16.96 7.63 1.66
2016-09-30 17.31 7.77 2.06
2016-06-30 17.07 7.83 1.55
2016-03-31 17.83 7.67 1.24
2015-12-31 21.78 7.76 2.00
2015-09-30 21.77 7.90 2.06
2015-06-30 21.54 5.79 1.50
2015-03-31 21.48 5.34 2.23
2014-12-31 21.68 5.31 2.54
2014-09-30 21.09 5.37 2.86
2014-06-30 20.63 5.42 3.39
2014-03-31 20.55 5.47 4.31
2013-12-31 21.02 5.51 2.51
2013-09-30 20.80 5.55 3.28
2013-06-30 20.44 5.57 3.10
2013-03-31 20.23 5.58 4.36
2012-12-31 17.43 2.35 3.61
  • Cyanotech's level of debt (61.4%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (26.2% vs 61.4% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Cyanotech has less than a year of cash runway based on current free cash flow.
  • Cyanotech has less than a year of cash runway if free cash flow continues to grow at historical rates of 33.3% each year.
X
Financial health checks
We assess Cyanotech's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Cyanotech has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

CYAN Dividends

 What is Cyanotech's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Cyanotech dividends.
If you bought $2,000 of Cyanotech shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Cyanotech's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Cyanotech's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:CYAN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.5%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1948 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Cyanotech has not reported any payouts.
  • Unable to verify if Cyanotech's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Cyanotech's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Cyanotech has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Cyanotech's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Cyanotech afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Cyanotech has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

CYAN Management

 What is the CEO of Cyanotech's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Gerry Cysewski
COMPENSATION $225,623
AGE 70
TENURE AS CEO 0.5 years
CEO Bio

Dr. Gerald R. Cysewski, Phd, also known as Gerry, Ph.D. co-founded Cyanotech Corp. in 1983 and has been its Director since that Time. Dr Cysewski serves as Chief Executive Officer at Cyanotech Corporation since May 23, 2019. Dr. Cysewski served as President and Chief Executive Officer from March 31, 2016 through January 24, 2018 at Cyanotech Corporation. Dr Cysewski had served as President since April 2019 until May 2019. Dr Cysewski had been Chief Scientific Officer at Cyanotech Corp. until April 2019 & serves as its Vice Chairman. Dr. Cysewski served as President of Cyanotech Corporation from August 25, 2016 to July 14, 2017. He served as an Executive Vice President of Cyanotech Corp. until March 31, 2016 and served as Chief Scientific Officer until May 2, 2016. Dr. Cysewski served as Executive Chairman of Cyanotech Corp. from October 1990 to May 16, 2008 and as its Chief Executive Officer and President from March 1990 to May 16, 2008. He served as Group Leader of Microalgae Research and Development of Battelle Northwest, a major contract research and development firm from 1980 to 1982. From 1976 to 1980, he served as an Assistant Professor in the Department of Chemical and Nuclear Engineering at the University of California, Santa Barbara, where he received a two-year grant from the National Science Foundation to develop a culture system for blue-green algae. From 1988 to November 1990, he served as Vice Chairman of Cyanotech Corp. He has been an Executive Director of Cyanotech Corp. since 1983. Dr. Cysewski continues to be recognized as a leading authority on large scale production of micro-algae and is a frequently invited speaker at industry gatherings around the world, providing insight to the Board on changes in micro-algae science and regulatory matters that impact the Company. Dr. Cysewski received his doctorate in Chemical Engineering from the University of California at Berkeley.

CEO Compensation
  • Gerry's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Gerry's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Cyanotech management team in years:

0.8
Average Tenure
61
Average Age
  • The average tenure for the Cyanotech management team is less than 2 years, this suggests a new team.
Management Team

Gerry Cysewski

TITLE
Co-Founder
COMPENSATION
$226K
AGE
70
TENURE
0.5 yrs

Brian Orlopp

TITLE
VP of Finance & Administration and CFO
COMPENSATION
$96K
AGE
58
TENURE
0.8 yrs

Amy Nordin

TITLE
Corporate Secretary

Glenn Jensen

TITLE
Vice President of Manufacturing & Infrastructure
COMPENSATION
$134K
AGE
61
TENURE
26.5 yrs
Board of Directors Tenure

Average tenure and age of the Cyanotech board of directors in years:

4.2
Average Tenure
62.5
Average Age
  • The tenure for the Cyanotech board of directors is about average.
Board of Directors

Michael Davis

TITLE
Independent Chairman of the Board
COMPENSATION
$70K
AGE
66
TENURE
8.6 yrs

Gerry Cysewski

TITLE
Co-Founder
COMPENSATION
$226K
AGE
70
TENURE
1.8 yrs

Walter Menzel

TITLE
Independent Director
COMPENSATION
$97K
AGE
72
TENURE
6.3 yrs

David Mulder

TITLE
Independent Director
COMPENSATION
$64K
AGE
57
TENURE
3.5 yrs

David Vied

TITLE
Independent Director
COMPENSATION
$70K
AGE
58
TENURE
4.8 yrs

Nancy Katz

TITLE
Independent Director
COMPENSATION
$64K
AGE
59
TENURE
3.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Cyanotech's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Cyanotech has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

CYAN News

Simply Wall St News

Does Cyanotech Corporation (NASDAQ:CYAN) Have A High Beta?

Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. … This means that -- if history is a guide -- buying the stock would reduce the impact of overall market volatility in many portfolios (depending on the beta of the portfolio, of course).

Simply Wall St -

Could The Cyanotech Corporation (NASDAQ:CYAN) Ownership Structure Tell Us Something Useful?

Taking a look at our data on the ownership groups (below), it's seems that institutional investors have bought into the company. … See our latest analysis for Cyanotech NasdaqCM:CYAN Ownership Summary, July 15th 2019 What Does The Institutional Ownership Tell Us About Cyanotech? … Insider Ownership Of Cyanotech The definition of company insiders can be subjective, and does vary between jurisdictions.

Simply Wall St -

Is Cyanotech Corporation (NASDAQ:CYAN) A Volatile Stock?

Every stock in the market is exposed to this volatility, which is linked to the fact that stocks prices are correlated in an efficient market. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market.

Simply Wall St -

Do Directors Own Cyanotech Corporation (NASDAQ:CYAN) Shares?

The big shareholder groups in Cyanotech Corporation (NASDAQ:CYAN) have power over the company. … Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … Cyanotech is a smaller company with a market capitalization of US$18m, so it may still be flying under the radar of many institutional investors.

Simply Wall St -

Cyanotech Corporation (NASDAQ:CYAN): A Look At Return On Capital

This is because the actual cash flow generated by the business dictates the potential for income (dividends) and capital appreciation (price increases), which are the two ways to achieve positive returns when buying a stock. … To understand Cyanotech’s capital returns we will look at a useful metric called return on capital employed. … This will tell us if the company is growing your capital and placing you in good stead to sell your shares at a profit

Simply Wall St -

Has Cyanotech Corporation's (NASDAQ:CYAN) Earnings Momentum Changed Recently?

Investors with a long-term horizong may find it valuable to assess Cyanotech Corporation's (NASDAQ:CYAN) earnings trend over time and against its industry benchmark as opposed to simply looking at a sincle earnings announcement at one point in time. … Below is my commentary, albiet very simple and high-level, on how Cyanotech is currently performing. … CYAN's trailing twelve-month earnings (from 31 March 2018) of US$1.03m has

Simply Wall St -

How Financially Strong Is Cyanotech Corporation (NASDAQ:CYAN)?

Cyanotech Corporation (NASDAQ:CYAN) is a small-cap stock with a market capitalization of US$23.09m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … So, understanding the company's financial health becomes

Simply Wall St -

What Kind Of Risk Should You Expect For Cyanotech Corporation (NASDAQ:CYAN)?

CYAN’s beta indicates it is a stock that investors may find valuable if they want to reduce the overall market risk exposure of their stock portfolio. … A market capitalisation of US$24.38M puts CYAN in the category of small-cap stocks, which tends to possess higher beta than larger companies. … Depending on the composition of your portfolio, low-beta stocks such as CYAN is valuable to lower your risk of market exposure, in particular, during times of economic decline.

Simply Wall St -

Who Are Cyanotech Corporation's (NASDAQ:CYAN) Major Shareholders?

Check out our latest analysis for Cyanotech NasdaqCM:CYAN Ownership_summary Apr 11th 18 Institutional Ownership With an institutional ownership of 38.31%, CYAN can face volatile stock price movements if institutions execute block trades on the open market, more so, when there are relatively small amounts of shares available on the market to trade Although CYAN has a high institutional ownership, such stock moves, in the short-term, are more commonly linked to a particular type of active institutional investors – hedge funds. … This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions. … This is an encouraging sign for investors as these investors tend to be active strategist in companies, focusing on increasing operational and capital efficiency for the firm.Next Steps: CYAN's considerably high level of institutional ownership calls for further analysis into its margin of safety.

Simply Wall St -

Why Cyanotech Corporation (NASDAQ:CYAN) May Not Be As Efficient As Its Industry

Check out our latest analysis for Cyanotech Peeling the layers of ROE – trisecting a company’s profitability Firstly, Return on Equity, or ROE, is simply the percentage of last years’ earning against the book value of shareholders’ equity. … Return on Equity = Net Profit ÷ Shareholders Equity ROE is assessed against cost of equity, which is measured using the Capital Asset Pricing Model (CAPM) – but let’s not dive into the details of that today. … This is called the Dupont Formula: Dupont Formula ROE = profit margin × asset turnover × financial leverage ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity) ROE = annual net profit ÷ shareholders’ equity NasdaqCM:CYAN Last Perf Apr 4th 18 Basically, profit margin measures how much of revenue trickles down into earnings which illustrates how efficient the business is with its cost management.

Simply Wall St -

CYAN Company Info

Description

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company’s products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, and direct to consumers, as well as in bulk form to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.

Details
Name: Cyanotech Corporation
CYAN
Exchange: NasdaqCM
Founded: 1983
$14,917,972
5,905,769
Website: http://www.cyanotech.com
Address: Cyanotech Corporation
73-4460 Queen Kaahumanu Highway,
Suite 102,
Kailua-Kona,
Hawaii, 96740,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM CYAN Common Stock Nasdaq Capital Market US USD 25. Oct 1985
Number of employees
Current staff
Staff numbers
109
Cyanotech employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/12 23:33
End of day share price update: 2019/11/12 00:00
Last earnings filing: 2019/08/13
Last earnings reported: 2019/06/30
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.